Fundz

Resolyst secures a significant investment to enhance its continuous care platform for chronic disease management, addressing the fragmented care issue. This funding will advance their innovative tools for specialists and patients.

PRIVATEJul 07, 2026

Round Type

Venture

BiotechnologyHealth CareMedical

Description

Resolyst has successfully closed a funding round aimed at improving its platform designed for chronic disease management. The investment will be used to enhance tools that provide continuous care and support to patients between appointments. By addressing the fragmented nature of patient care, Resolyst aims to improve outcomes for those with long-term conditions.

Quick answer

Resolyst raised an undisclosed amount in a funding round, dated July 16, 2026.

How much did Resolyst raise?
Resolyst raised an undisclosed amount in a funding round on July 16, 2026.
What does Resolyst do?
Resolyst is a platform designed to improve chronic disease management by providing a clinical workflow layer that operates between patient appointments and across various specialties.
Where is Resolyst based and how big is it?
Fundz records about 2 employees.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as Resolyst that raised within 45 days of this round, from Fundz verified event records.

  • Clementine raised $2M (Seed) on August 28, 2026.
  • Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.
  • MiMARK Diagnostics raised $4.9M (Seed) on August 26, 2026.
  • Gestala Technology raised $84M (Angel) on August 26, 2026.
  • LymeLess Health raised an undisclosed amount (Seed) on August 22, 2026.
  • Odysight.ai raised $11M (Post-IPO Equity) on August 21, 2026.

Who to call at Resolyst, and when

A new round usually means Resolyst is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Resolyst raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Resolyst, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Resolyst. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Resolyst

About

Resolyst is a platform designed to improve chronic disease management by providing a clinical workflow layer that operates between patient appointments and across various specialties. It enables continuous care by allowing patients to log symptoms and be monitored outside of traditional visits, while also offering specialists oversight of their patients' caseloads. By ensuring structured interactions, Resolyst not only enhances patient care but also generates valuable research-grade datasets for life sciences. The founder, Molly, has a strong background in healthcare strategy and investment, making her well-equipped to lead this initiative.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Resolyst raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Resolyst's next move

See what Strategic adds

Resolyst raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.